Visão geral do mercado

The global wearable patches market has shown significant growth in recent years and is projected to continue expanding. In 2021, the market was valued at $8.65 billion, and it is estimated to reach $26.89 billion by the end of 2031, with a CAGR of 11.06% during the forecast period of 2022-2031. This growth is driven by several factors, including the ability of wearable patches to continuously monitor vital signs with minimal interference in body movement, the increasing prevalence of chronic disorders such as diabetes and strokes, advancements in technology that enable enhanced connectivity with cellphones and provide precise data, and the growing geriatric population.

The global wearable patches market encompasses various types of patches used in therapeutics, monitoring, and diagnostics for a range of chronic conditions. These patches enable the monitoring of parameters like heart rate, blood glucose levels, blood pressure, SpO2 levels, and temperature, among others. Market players offer a wide variety of wearable patches tailored to meet the demands of monitoring, diagnostics, and therapeutics. These companies focus on aligning their product portfolios with current market trends, such as the development of multifunctional patches.

The industry has demonstrated its adaptability and versatility during this rapid expansion. The pandemic highlighted the necessity of utilizing digital infrastructure for remote monitoring. Wearable sensors have the potential to facilitate more effective disease monitoring and detection for individual and public health, even beyond COVID-19 testing and vaccines. Although further research is required, the application of wearable technology can help predict the probability of COVID-19 and associate physiological measures with daily activities and human performance. By combining wearable technology with predictive platforms, users could receive alerts when changes in their parameters indicate a potential link to COVID-19.

There are several drivers fueling the global wearable patches market, including the need for continuous monitoring with minimal interference, the increasing prevalence of chronic disorders, advancements in technology enabling connectivity and precise data, and the growing geriatric population.

However, there are also challenges and limitations that the market faces. These include the high cost of wearable patches and a lack of adequate reimbursement, which hinder their widespread adoption. Concerns regarding data privacy and security of the information collected from wearable patches also pose challenges to market growth. Nonetheless, as technology advances, these limitations can be addressed to drive further growth in the wearable patches market.

Segmentação de mercado

The market is segmented based on various factors, including application, usage type, end user, and region.

Segmentation by Application
Monitoring and Diagnostics
Therapeutics

Segmentation by Usage Type
Temperature Patch
Blood Glucose Patch
Heart Rate and ECG Patch
TENS and EMS Patch
Others

Segmentation by End User
Hospital and Ambulatory Surgical Center
Homecare

Segmentation by Region
North America – U.S. and Canada
Europe – Alemanha, França, U.K., Itália, Espanha, and Rest-of-Europe
Asia-Pacific – Japão, China, Índia, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
Latin America – Brasil, México, and Rest-of-Latin America
Middle East and Africa – U.A.E., África do Sul, and Rest-of-Middle East and Africa

The global wearable patches market is segmented into monitoring and diagnostics, as well as therapeutics, based on application. In 2021, the monitoring and diagnostics segment accounted for a majority share of the market. Specifically, it held a 72.51% share of the overall market, and it is anticipated to experience robust growth at a CAGR of 10.41% during the forecast period of 2022-2031. This growth is primarily driven by the increasing prevalence of chronic diseases and the growing geriatric population. Wearable patches are widely used for monitoring and diagnosing vital parameters such as blood pressure, pulse rate, and blood glucose levels. Equipped with multiple sensors, these patches adhere to the skin using a skin adhesive and are typically non-invasive, making them patient-friendly.

During the period 2021-2031, the blood glucose patch segment is expected to create the maximum incremental opportunity of $14.19 billion. Blood glucose patches are non-invasive and adhesive patches used for continuous monitoring of glucose levels in individuals. They have unlocked the potential for non-invasive diabetes control. Glucose monitoring devices with sensors are utilized for measuring glucose levels, and insulin pumps provide continuous insulin delivery to improve blood sugar levels. The demand for blood glucose patches is increasing due to the rising popularity of homecare devices. However, it’s worth noting that security vulnerabilities associated with the use of remote controller accessories with insulin pumps have resulted in pump recalls.

In the same forecast period, the homecare segment is anticipated to create the maximum incremental opportunity of $15.14 billion. Remote healthcare monitoring offers an efficient and cost-effective alternative to on-site clinical monitoring, allowing patients to stay at home and avoid costly hospital or clinic treatments. The COVID-19 pandemic has led to increased usage of pulse oximeters for estimating blood oxygen levels. Profusa Inc., for example, obtained CE mark approval for its Wireless Lumee Oxygen device, which enables patients to monitor tissue oxygen levels at home. This monitoring device collects real-time information about the patient’s health and comprises flexible sensors that can be attached to various materials or directly to the body. It facilitates the monitoring and diagnosis of cardiovascular, pulmonary, and neurological diseases, enabling remote healthcare monitoring and accurate information gathering.

Regions with technologically advanced healthcare systems and favorable reimbursement policies, such as North America and Europe, currently hold the largest share in the global wearable patches market. These regions allocate significant budgets to healthcare systems and have a high level of awareness regarding healthcare technologies. However, Asia-Pacific and Latin America are expected to witness substantial growth during the forecast period due to increasing chronic disease cases and growing healthcare awareness.

North America dominated the wearable patches market in 2021, and this trend is projected to continue from 2022 to 2031. The region’s dominance can be attributed to the presence of major market players and increasing investments by public and private organizations in the adoption of innovative solutions using different technologies and software. Notably, the U.S. is home to several innovative and emerging companies developing next-generation wearable devices. For instance, VitalConnect, Inc. launched the VitalPatch RTM cardiac monitoring solution in November 2020 for patients requiring Holter monitoring. The U.S. is expected to create the maximum incremental opportunity of $5.55 billion during the period 2021-2031.

Cenário competitivo

The selection of the featured companies was made through a meticulous process involving inputs from primary experts and a thorough analysis of company coverage, product portfolio, and market penetration.

Key companies profiled in this report include Abbott Laboratories, Bittium Corporation, Boston Scientific Corporation, iRhythm Technologies, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, OMRON Corporation, Senseonics Holdings, Inc., Alio, Inc., AliveCor Inc., BioIntellisense, Inc., Samay, Theranica Bio-Electronics Ltd., VitalConnect Inc., VivaLNK Inc.

Recent Industry Developments

In September 2022, Senseonics announced a collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio.

During June 2022, Abbott disclosed its development of a novel biowearable called the Glucose-Ketone Monitoring System. This system will enable continuous monitoring of glucose and ketone levels using a single sensor.

Also in June 2022, Blue Spark Technologies joined Medidata’s Sensor Cloud Network, a platform that aims to overcome barriers hindering the widespread adoption of medical sensors. This includes addressing issues related to data integration and standardization.

In May 2022, BioIntelliSense introduced a new product called the BioButton Rechargeable Wearable Device, designed for continuous medical-grade monitoring of over 20 vital signs and biometrics.

In April 2022, Blue Spark secured a funding of $40 million for the development of remote monitoring wearables.

During April 2022, Carevive Systems and Blue Spark Technologies formed a partnership to conduct a Real-Time Remote Patient Monitoring Pilot.

In the same month, Insulet launched the New Omnipod 5 System Data, catering to individuals with Type 1 and Type 2 Diabetes.

Key Questions Answered

How has the COVID-19 pandemic affected the growth of the global market for wearable patches?

What are the significant regulations that govern the wearable patches market in key regions?

What are some of the opportunities for growth that market players can take advantage of?

What are the factors driving and restraining the growth of the global market for wearable patches?

Which region is experiencing the highest growth rate in the market for wearable patches?

What are the key strategies being implemented by market players in the global market for wearable patches?

What are the emerging technologies in the global market for wearable patches?